Neptune Technologies & Bioresources Inc Competitors

NEPT 
$1.95
*  
0.05
2.5%
Get NEPT Alerts
*Delayed - data as of Aug. 20, 2014 12:00 ET  -  Find a broker to begin trading NEPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    NEPT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time

Competitor Industry: Major Pharmaceuticals

Neptune Technologies & Bioresources Inc
CompanyName ▲
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Abbott Laboratories
ABT: NYSE
$ 42.32 -0.22 ▼ 1,370,446 $ 42.49
$ 42.05
$ 43.27
$ 32.70
27.84 63,636,541,680
AbbVie Inc.
ABBV: NYSE
$ 54.88 -0.41 ▼ 2,464,632 $ 55.10
$ 54.69
$ 58.27
$ 42.25
21.19 87,352,441,120
ACADIA Pharmaceuticals Inc.
ACAD: NASDAQ-GS
$ 22.502 -0.07 ▼ 271,073 $ 22.653
$ 22.26
$ 32
$ 15.64
NE 2,227,157,952
Acasti Pharma, Inc.
ACST: NASDAQ-CM
$ .95 0.04 ▲ 336,692 $ 1
$ .9101
$ 3.10
$ .80
NE 100,568,900
AcelRx Pharmaceuticals, Inc.
ACRX: NASDAQ-GM
$ 6.60 -0.18 ▼ 159,915 $ 6.80
$ 6.55
$ 13.64
$ 6.04
NE 285,885,600
Achaogen, Inc.
AKAO: NASDAQ-GM
$ 9.23 -0.06 ▼ 14,737 $ 9.46
$ 9.16
$ 19.69
$ 9.01
NE 163,195,630
Achillion Pharmaceuticals, Inc.
ACHN: NASDAQ-GS
$ 9.8999 0.03 ▲ 3,657,321 $ 10.18
$ 9.63
$ 10.10
$ 2.26
NE 958,270,720
Actavis, Inc.
ACT: NYSE
$ 222.27 -0.81 ▼ 552,077 $ 223.33
$ 221.57
$ 230.77
$ 136.52
483.2 58,737,292,470
Acura Pharmaceuticals, Inc.
ACUR: NASDAQ-CM
$ .899 0.02 ▲ 7,066 $ .90
$ .88
$ 2.23
$ .8121
NE 43,914,352
Adamas Pharmaceuticals, Inc.
ADMS: NASDAQ-GM
$ 17.42 -0.54 ▼ 6,482 $ 18.53
$ 17.145
$ 21.6299
$ 12.02
NE 291,924,360
Adamis Pharmaceuticals Corporation
ADMP: NASDAQ-CM
$ 3.68 0.29 ▲ 138,011 $ 3.8099
$ 3.43
$ 7.25
$ 2.62
NE 38,647,360
Advaxis, Inc.
ADXS: NASDAQ-CM
$ 2.82 0.03 ▲ 16,501 $ 2.82
$ 2.75
$ 11.70
$ 2.46
NE 54,349,860
Advaxis, Inc.
ADXSW: NASDAQ-CM
$ 1 unch n/a
n/a
$ 2.63
$ .75
NE 4,140,000
Aegerion Pharmaceuticals, Inc.
AEGR: NASDAQ-GS
$ 30.93 0.21 ▲ 482,563 $ 31.50
$ 30.51
$ 101
$ 26.25
NE 911,909,190
AEterna Zentaris Inc.
AEZS: NASDAQ-CM
$ 1.345 0.02 ▲ 838,373 $ 1.36
$ 1.33
$ 1.75
$ .99
NE 76,011,330
Agile Therapeutics, Inc.
AGRX: NASDAQ-GM
$ 7.76 0.34 ▲ 14,494 $ 7.8099
$ 7.4526
$ 12.55
$ 5.05
NE 144,273,920
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 41.21 -0.57 ▼ 40,906 $ 41.94
$ 41.05
$ 50.37
$ 15.77
NE 1,399,326,760
Akebia Therapeutics, Inc.
AKBA: NASDAQ-GM
$ 23.66 -0.61 ▼ 17,630 $ 24.31
$ 23.55
$ 31
$ 16.41
NE 479,398,920
Akorn, Inc.
AKRX: NASDAQ-GS
$ 37.33 -0.49 ▼ 281,552 $ 37.76
$ 37.1201
$ 38.61
$ 16
93.33 3,879,408,260
Alcobra Ltd.
ADHD: NASDAQ-GM
$ 20.95 0.28 ▲ 31,372 $ 21.07
$ 20.28
$ 26.96
$ 12.04
NE 285,695,150
Alder BioPharmaceuticals, Inc.
ALDR: NASDAQ-GM
$ 16.30 -0.29 ▼ 26,675 $ 16.608
$ 16.28
$ 22.95
$ 9.50
NE 502,105,200
Aldeyra Therapeutics, Inc.
ALDX: NASDAQ-CM
$ 4.05 -0.09 ▼ 464 $ 4.05
$ 3.84
$ 8.2223
$ 3
NE 22,538,250
Alexion Pharmaceuticals, Inc.
ALXN: NASDAQ-GS
$ 168.69 -1.07 ▼ 350,533 $ 169.9122
$ 167.55
$ 185.43
$ 100.89
84.77 33,366,207,240
Alexza Pharmaceuticals, Inc.
ALXA: NASDAQ-GM
$ 3.63 0.01 ▲ 107,621 $ 3.67
$ 3.53
$ 5.93
$ 3.4101
NE 62,871,600
Alimera Sciences, Inc.
ALIM: NASDAQ-GM
$ 5.70 -0.05 ▼ 23,881 $ 5.77
$ 5.63
$ 8.44
$ 1.65
NE 229,858,200